Comparative efficacy of risdiplam and nusinersen in Type 2 and 3 spinal muscular atrophy patients: A cohort study using real-world data.
Ashrafi MR, Babaee M, Hashemi Nazari SS, Barzegar M, Ghazavi M, Beiraghi Toosi M, Nafissi S, Inaloo S, Zamani Ghaletaki G, Fatehi F, Heshmat R, Ghahvechi Akbari M, Abdi A, Bakhtiary H, Montazerlotfelahi H, Abbaskhanian A, Hosseini SA, Farshadmoghadam H, Hosseiny SMM, Shariatmadari F, Ziaadini B, Babaei M, Tavasoli A, Nikbakht S, Momen A, Khajeh A, Aminzadeh V, Mollamohammadi M, Taghdiri MM, Nasehi MM, Memarian S, Badv RS, Heidari M, Jafari N.
Ashrafi MR, et al.
J Neuromuscul Dis. 2024 Nov;11(6):1190-1199. doi: 10.1177/22143602241288087. Epub 2024 Dec 20.
J Neuromuscul Dis. 2024.
PMID: 39967428
Free article.